logo
  • SELECT LICENSE :

  • US $4,299.00
  • US $8,599.00

Breast Implants Market, By Type (Silicone, Saline), By Application (Cosmetic Surgery, Reconstructive Surgery) By End User (Hospital, ASC, Cosmetology Clinics) opportunities and forecast 2020-2027

  • DLR2150
  • 20 September, 2020
  • Pharma & Healthcare
  • Pages: 120
  • Global
Market Overview

Breast implantation surgical procedure has evolved greatly with the growing demand for the surgeries. Women with the high preference for enhancing the aesthetic appeal contribute principally to the revenue of the breast implantation market. According to FDA, women above the age of 18 years can undergo the breast augmentation surgeries.

Rising incidence of breast cancer is a significant driver leading to growth of the market. In severe cases, prevention of this disease includes mastectomy surgery that requires removal of entire organ. In addition, reform or reconstruction of the organ is considered as useful option for treatment of the disease. The procedure involves reconstructing the shape of removed organ. Thus, with the rising number of reform cases, there is growing demand for the breast implantation.
The American Society of Plastic Surgeons stated that breast amplification is one of the top five cosmetic procedures performed in the U.S. As per the organization, 279,143 number of processes related to augmentation had taken place in the U.S. Hence, with huge number of such cases, the growth of the market is expected to increase over the coming years.

Segment Overview

Based on product segment, silicone implants commanded largest market share in 2019 due to the fact that the devices tend to be similar to the natural breast tissue. Gummy implant gives natural shape to the recreated breast. The product segment does not pose any risk for disorders related with the immune system.
Moreover, silicone implants are anticipated to showcase the highest growth over forecast period owing to the soft texture this feature reduces the risk of formation of solid scar tissue around implantation. Additionally, gummy implants also have low risk of wrinkling.

Regional Overview

In 2019, North America lead the market owing to increasing healthcare spending in U.S. and the rising demand for various cosmetic surgical procedures associated with improvement of aesthetics in the country. Moreover, growing prevalence of breast cancer in the region is also anticipated to strengthen the growth of market.
Europe also commanded t significant share in 2019 owing to huge awareness levels concerning cosmetic surgeries in the region. Furthermore, introduction of large number of various cosmetology clinics in Europe has further supported the growth of the regional market.

Asia Pacific is likely to showcase lucrative growth during the forecast period. This is due to rising disposable income in developing countries. Furthermore, the region provides huge opportunity to the low-cost treatments in medical tourism. Therefore, the aforementioned factors are projected to drive the market growth.

Competitor overview

The main strategies of the companies include mergers & acquisitions, new product development, and geographical expansions. For example, in 2016, Allergan plc had U.S. FDA approval for NATRELLE INSPIRA Cohesive implants, a new introduction in the gummy breast implants category.

Key Players
  1. ALLERGAN;
  2. GC Aesthetics;
  3. GROUPE SEBBIN SAS;
  4. Mentor Worldwide LLC;
  5. Sientra, Inc.;
  6. Polytech Health & Aesthetics GmbH;
  7. Establishment Labs S.A.;
  8. Shanghai Kangning Medical Supplies Ltd.;
  9. Guangzhou Wanhe Plastic Materials Co., Ltd.;
  10. LABORATOIRES ARION;
  11. HANSBIOMED CO. LTD.

Market Segmentation

By Type
  • Silicon
  • Saline
By Application
  • Cosmetic Surgery
  • Reconstructive Surgery
By End User
  • Hospitals
  • Ambulatory Surgical Centers
  • Cosmetology Clinics
By Geography
  • North America
    • US
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • UAE
    • Rest of LAMEA


1 Report Prologue 14

    2 Market Introduction 16

    • 2.1 Scope of Study 17
    • 2.2 Research Objective 17
    • 2.3 List of Assumptions 17

    3 Research Methodology 19

    • 3.1 Research Process 20
    • 3.2 Primary Research 21
    • 3.3 Secondary Research 22
    • 3.4 Market Size Estimation 23

    4 Market Dynamics 24

    • 4.1 Introduction 25
    • 4.2 Drivers 25
      • 4.2.1 Increasing demand for female aesthetic solutions 25
      • 4.2.2 Rising technological advancements in breast implant products 25
      • 4.2.3 Increasing beauty consciousness 25
    • 4.3 Restraints 26
      • 4.3.1 Side-effects and complications associated during surgery 26
      • 4.3.2 Higher cost related to the surgery and the implant 26

    5 Market Factor Analysis 27

    • 5.1 Porters Five Forces Analysis 28
      • 5.1.1 Overview 28
      • 5.1.2 Bargaining Power of Suppliers 28
      • 5.1.3 Bargaining Power of Buyers 28
      • 5.1.4 Threat of New Entrants 28
      • 5.1.5 Threat of Substitutes 29
      • 5.1.6 Rivalry 29
    • 5.2 Value Chain Analysis 29
      • 5.2.1 Overview 29
      • 5.2.2 Supporting Activity 29
      • 5.2.3 Inbound Logistics 29
      • 5.2.4 Production and Operation 30
      • 5.2.5 Outbound Logistics 30
      • 5.2.6 Marketing and Sales 30
      • 5.2.7 Customer Services 30

    6 Global Breast Implant Market, by Product Type 31

    • 6.1 Introduction 32
    • 6.2 Silicone 33
    • 6.3 Saline 34

    7 Global Breast Implant Market, by Shape 35

    • 7.1 Introduction 36
    • 7.2 Round Breast Implants 37
    • 7.3 Anatomical Breast Implants 37

    8 Global Breast Implant Market, by Application 38

    • 8.1 Introduction 39
    • 8.2 Breast Augmentation 40
    • 8.3 Breast Reconstruction 41

    9 Global Breast Implant Market, by End User 42

    • 9.1 Introduction 43
    • 9.2 Hospitals & Clinics 44
    • 9.3 Ambulatory Surgical Centers 44
    • 9.4 Cosmetic Surgery Centers 45

    10 Global Breast Implant Market, by Region 46

    • 10.1 Introduction 47
    • 10.2 Americas 49
      • 10.2.1 North America 51
        • 10.2.1.1 US 53
        • 10.2.1.2 Canada 54
      • 10.2.2 South America 56
        • 10.2.2.1 Brazil 58
        • 10.2.2.2 Columbia 59
        • 10.2.2.3 Mexico 61
  • 10.3 Europe 63
    • 10.3.1 Western Europe 65
      • 10.3.1.1 Germany 67
      • 10.3.1.2 UK 69
      • 10.3.1.3 France 70
      • 10.3.1.4 Italy 72
      • 10.3.1.5 Spain 73
      • 10.3.1.6 Netherland 75
      • 10.3.1.7 Switzerland 76
      • 10.3.1.8 Rest of Western Europe 78
    • 10.3.2 Nordic Countries 79
    • 10.3.3 Eastern Europe 81
      • 10.3.3.1 Russia 82
      • 10.3.3.2 Res of Eastern Europe 84
  • 10.4 Asia-Pacific 86
    • 10.4.1 Japan 88
    • 10.4.2 China 90
    • 10.4.3 India 91
    • 10.4.4 Australia 93
    • 10.4.5 South Korea 94
    • 10.4.6 Taiwan 96
    • 10.4.7 Thailand 97
    • 10.4.8 Vietnam 99
    • 10.4.9 Rest of Asia-Pacific 100
  • 10.5 Rest of The World 102
  • 11 Competitive Landscape 104

    • 11.1 Introduction 105

    12 Company Profiles 106

    • 12.1 Allergan Inc. 107
      • 12.1.1 Company Overview 107
      • 12.1.2 Financial Overview 107
      • 12.1.3 Products/Services Offered 108
      • 12.1.4 Key Developments 108
      • 12.1.5 SWOT Analysis 108
      • 12.1.6 Key Strategy 108
    • 12.2 Sientra Inc. 109
      • 12.2.1 Company Overview 109
      • 12.2.2 Financial Overview 109
      • 12.2.3 Products/Services Offered 110
      • 12.2.4 Key Developments 110
      • 12.2.5 SWOT Analysis 111
      • 12.2.6 Key Strategy 111
    • 12.3 GC Aesthetics 112
      • 12.3.1 Company Overview 112
      • 12.3.2 Financial Overview 112
      • 12.3.3 Products/Services Offered 112
      • 12.3.4 Key Developments 113
      • 12.3.5 SWOT Analysis 113
      • 12.3.6 Key Strategy 113
    • 12.4 Mentor Worldwide LLC (Part of Johnson & Johnson) 114
      • 12.4.1 Company Overview 114
      • 12.4.2 Financial Overview 114
      • 12.4.3 Products/Services Offered 115
      • 12.4.4 Key Developments 116
      • 12.4.5 SWOT Analysis 116
      • 12.4.6 Key Strategy 117
    • 12.5 Establishment Labs 118
      • 12.5.1 Company Overview 118
      • 12.5.2 Financial Overview 118
      • 12.5.3 Products/Services Offered 118
      • 12.5.4 SWOT Analysis 118
      • 12.5.5 Key Developments 118
      • 12.5.6 Key Strategy 118
    • 12.6 Polytech Health & Aesthetics GmbH (Deutsche Beteiligungs AG) 119
      • 12.6.1 Company Overview 119
      • 12.6.2 Financial Overview 119
      • 12.6.3 Products/Services Offered 119
      • 12.6.4 SWOT Analysis 120
      • 12.6.5 Key Developments 120
      • 12.6.6 Key strategy 120
    • 12.7 Groupe Sebbin SAS 121
      • 12.7.1 Company Overview 121
      • 12.7.2 Financial Overview 121
      • 12.7.3 Products/Services Offered 121
      • 12.7.4 Key Developments 121
      • 12.7.5 SWOT Analysis 121
      • 12.7.6 Key Strategy 122
    • 12.8 HansBiomed Co. Ltd 123
      • 12.8.1 Company Overview 123
      • 12.8.2 Financial Overview 123
      • 12.8.3 Products/Services Offered 123
      • 12.8.4 Key Developments 123
      • 12.8.5 SWOT Analysis 123
      • 12.8.6 Key Strategy 124
    • 12.9 Laboratoires Arion 125
      • 12.9.1 Company Overview 125
      • 12.9.2 Financial Overview 125
      • 12.9.3 Products/Services Offered 125
      • 12.9.4 Key Developments 125
      • 12.9.5 SWOT Analysis 125
      • 12.9.6 Key Strategy 125
    • 12.10 Cereplas 126
      • 12.10.1 Company Overview 126
      • 12.10.2 Financial Overview 126
      • 12.10.3 Products/Services Offered 126
      • 12.10.4 Key Developments 126
      • 12.10.5 SWOT Analysis 126
      • 12.10.6 Key strategy 126
    • 12.11 Ideal Implant Inc. 127
      • 12.11.1 Company Overview 127
      • 12.11.2 Financial Overview 127
      • 12.11.3 Products/Services Offered 127
      • 12.11.4 Key Developments 127
      • 12.11.5 SWOT Analysis 127
      • 12.11.6 Key Strategy 127
    • 12.12 Shanghai Kangning Medical Supplies Ltd 128
      • 12.12.1 Company Overview 128
      • 12.12.2 Financial Overview 128
      • 12.12.3 Products/Services Offered 128
      • 12.12.4 Key Developments 128
      • 12.12.5 SWOT Analysis 129
      • 12.12.6 Key strategy 129
    • 12.13 Guangzhou Wanhe Plastic Materials Co. Ltd 130
      • 12.13.1 Company Overview 130
      • 12.13.2 Financial Overview 130
      • 12.13.3 Products/Services Offered 130
      • 12.13.4 Key Developments 130
      • 12.13.5 SWOT Analysis 130
      • 12.13.6 Key Strategy 131

    13 Appendix 132

    • 13.1 Discussion Blue Print 133

    Report You Might be Interested